Natural History in Children up to 16 Years With Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes

Recruiting Observational Study
Sensorineural Hearing Loss, Bilateral AUNB1 DFNB1A Congenital Deafness DFNB9 OTOF Gene Mutation GJB2 Gene Mutation
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 16
Sex
Any
Study type
Observational
Participants needed
180 (estimated)
Sponsor
Sensorion · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to follow the natural history of non-syndromic hearing loss caused by mutations in two genes (GJB2 or OTOF) in children up to 16 years of age.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Main Inclusion Criteria: Participants meeting all the following main inclusion criteria will be eligible to participate in the study: * Aged ≤ 16 years on the date of signed informed consent for cohort 1 and ≤ 10 years for cohort 2; * With a diagnosis of non-syndromic, bilateral, mild to profound,…
Contacts

Lionel HOVSEPIAN, MD

+33 (0)7 86 31 13 76

lionel.hovsepian@sensorion-pharma.com

CONTACT